Literature DB >> 835529

Respiratory syncytial virus in early infancy. Circulating antibody and the severity of infection.

F W Bruhn, A S Yeager.   

Abstract

Forty-one children less than 6 months of age from whom respiratory syncytial virus (RSV) was isolated were divided into groups of varying severity of illness. No relationship was demonstrated between severity of illness and the complement fixation titer to RSV in cord sera, acute sera, or convalescent sera. An increase in IgM level of greater or equal to 15 mg/100 ml in association with the RSV infection was seen more frequently in infants who had higher IgM levels in their acute sera than in infants who had lower levels.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 835529     DOI: 10.1001/archpedi.1977.02120150027004

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  16 in total

Review 1.  The respiratory syncitial virus and its role in acute bronchiolitis.

Authors:  M L Everard; A D Milner
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

Review 2.  Immunity to human and bovine respiratory syncytial virus.

Authors:  T G Kimman; F Westenbrink
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

3.  Polymorphonuclear function and respiratory syncytial virus infections in children.

Authors:  A Martini; L D Notarangelo; G L Marseglia; L Barberis; M Marconi; S Guarnaccia; A G Ugazio
Journal:  Infection       Date:  1983 Jul-Aug       Impact factor: 3.553

Review 4.  Respiratory syncytial virus. Brief review.

Authors:  E J Stott; G Taylor
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

5.  Development of cell-mediated cytotoxic activity in the respiratory tract after experimental infection with respiratory syncytial virus.

Authors:  T Kumagai; D T Wong; P L Ogra
Journal:  Clin Exp Immunol       Date:  1985-08       Impact factor: 4.330

Review 6.  Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections.

Authors:  V G Hemming; G A Prince; J R Groothuis; G R Siber
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

7.  Virus-induced complement activation and neutrophil-mediated cytotoxicity against respiratory syncytial virus (RSV).

Authors:  T N Kaul; H Faden; R Baker; P L Ogra
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

8.  Neutralization of respiratory syncytial virus after cell attachment.

Authors:  C Osiowy; R Anderson
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

9.  IgG and IgM antibodies to viral glycoproteins in respiratory syncytial virus infections of graded severity.

Authors:  G L Toms; M S Webb; P D Milner; A D Milner; E G Routledge; R Scott; G M Stokes; A Swarbrick; C E Taylor
Journal:  Arch Dis Child       Date:  1989-12       Impact factor: 3.791

10.  Ontogenesis of the formation of secretory antibodies to respiratory syncytial (RS) virus.

Authors:  N P Leschinskaya; E E Pokrovskaya; E A Kantorovitch; S K Grigorjeva
Journal:  Epidemiol Infect       Date:  1988-12       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.